Login / Signup

Transcriptomic, Proteomic, and Morphologic Characterization of Healing in Volumetric Muscle Loss.

Raphael J CrumScott A JohnsonPeng JiangJayati H JuiRuben ZamoraDevin CortesMangesh KulkarniArchana PrabaharJennifer BolinEric GannEric ElsterSeth A SchobelDale LarieChase CockrellGary AnBryan BrownMilos HauskrechtYoram VodovotzStephen F Badylak
Published in: Tissue engineering. Part A (2022)
Skeletal muscle has a robust, inherent ability to regenerate in response to injury from acute to chronic. In severe trauma, however, complete regeneration is not possible, resulting in a permanent loss of skeletal muscle tissue referred to as volumetric muscle loss (VML). There are few consistently reliable therapeutic or surgical options to address VML. A major limitation in investigation of possible therapies is the absence of a well-characterized large animal model. In this study, we present results of a comprehensive transcriptomic, proteomic, and morphologic characterization of wound healing following VML in a novel canine model of VML which we compare to a nine-patient cohort of combat-associated VML. The canine model is translationally relevant as it provides both a regional (spatial) and temporal map of the wound healing processes that occur in human VML. Collectively, these data show the spatiotemporal transcriptomic, proteomic, and morphologic properties of canine VML healing as a framework and model system applicable to future studies investigating novel therapies for human VML. Impact Statement The spatiotemporal transcriptomic, proteomic, and morphologic properties of canine volumetric muscle loss (VML) healing is a translational framework and model system applicable to future studies investigating novel therapies for human VML.
Keyphrases
  • skeletal muscle
  • endothelial cells
  • wound healing
  • single cell
  • rna seq
  • stem cells
  • pluripotent stem cells
  • label free
  • case report
  • electronic health record
  • metabolic syndrome
  • hepatitis b virus